References

Unresolved reference

External reference

Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studies

10.1002/1097-0142(19950715)76:2<333::aid-cncr2820760226>3.0.co;2-i · 1995 · External reference

Representation of older patients in cancer treatment trials

10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · 1994 · External reference

Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups

10.1200/jco.2006.09.2759 · 2007 · External reference

Understanding the attitudes of the elderly towards enrolment into cancer clinical trials

10.1186/1471-2407-6-34 · 2006 · External reference

Aging, frailty, and chemotherapy

10.1177/107327480701400102 · 2007 · External reference

Greater risks of chemotherapy toxicity in elderly patients with cancer

2003 · External reference

Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study

10.1200/jco.20.2.494 · 2002 · External reference

Impairment in functional status and survival in patients with acute myeloid leukaemia

10.1007/s00432-006-0115-7 · 2006 · External reference

Multidimensional geriatric assessment in treatment decision in elderly cancer patients: 6-year experience in an outpatient geriatric oncology service

10.1016/j.critrevonc.2008.07.003 · 2008 · External reference

Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine

10.1007/s12094-007-0019-2 · 2007 · External reference

10.1200/jco.2005.02.527

10.1200/jco.2005.02.527 · 2005 · External reference

Best paper of the 1980s: National Institutes of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision-making. 1988

10.1046/j.1532-5415.2003.51471.x · 2003 · External reference

A practical approach to geriatric assessment in oncology

10.1200/jco.2006.10.2954 · 2007 · External reference

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)

10.1016/j.critrevonc.2005.06.003 · 2005 · External reference

Comprehensive geriatric assessment for older patients with cancer

10.1200/jco.2007.10.6559 · 2007 · External reference

Cancer and comorbidity: redefining chronic diseases

10.1002/(sici)1097-0142(20000201)88:3<653::aid-cncr24>3.0.co;2-1 · 2000 · External reference

Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study

10.1002/(sici)1097-0142(19980601)82:11<2123::aid-cncr6>3.0.co;2-w · 1998 · External reference

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55years and older

10.1001/jama.285.7.885 · 2001 · External reference

Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale

10.1016/j.critrevonc.2006.11.001 · 2007 · External reference

Measurement and impact of comorbidity in older cancer patients

10.1016/s1040-8428(00)00090-1 · 2000 · External reference

Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study

10.1002/cncr.21354 · 2005 · External reference

Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

10.1002/cncr.23462 · 2008 · External reference

Association of comorbidity with disability in older women: the Women's Health and Aging Study

10.1016/s0895-4356(98)00124-3 · 1999 · External reference

Comorbidity and functional status are independent in older cancer patients

10.1200/jco.1998.16.4.1582 · 1998 · External reference

Gemcitabine and cisplatin in the treatment of elderly patients with advanced non-small cell lung cancer: impact of comorbidities on safety and efficacy outcome

10.1179/joc.2005.17.6.685 · 2005 · External reference

Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel

10.1080/02841860600833178 · 2007 · External reference

Effects of comorbidity on screening and early diagnosis of cancer in elderly people

10.1016/s1470-2045(08)70336-x · 2009 · External reference

How to measure comorbidity. a critical review of available methods

10.1016/s0895-4356(02)00585-1 · 2003 · External reference

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

10.1016/0021-9681(87)90171-8 · 1987 · External reference

Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery

10.1016/j.jclinepi.2005.07.015 · 2006 · External reference

Cumulative illness rating scale

10.1111/j.1532-5415.1968.tb02103.x · 1968 · External reference

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

10.1016/0165-1781(92)90005-n · 1992 · External reference

Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged >80years

10.3816/clc.2007.n.013 · 2007 · External reference

Cancer and comorbidity in older patients: a descriptive profile

10.1016/s1047-2797(96)00063-4 · 1996 · External reference

Step by step development of clinical care pathways for older cancer patients: necessary or desirable?

10.1016/j.ejca.2007.08.004 · 2007 · External reference

Participation of patients 65years of age or older in cancer clinical trials

10.1200/jco.2003.08.010 · 2003 · External reference

International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency

10.1016/j.ejca.2006.11.004 · 2007 · External reference

Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach

10.1016/j.critrevonc.2005.04.008 · 2005 · External reference

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005

10.1038/sj.bjc.6603717 · 2007 · External reference

Breast cancer treatment of older women in integrated health care settings

10.1200/jco.2006.06.3065 · 2006 · External reference

The effects of mammographic detection and comorbidity on the survival of older women with breast cancer

10.1046/j.1532-5415.2002.50261.x · 2002 · External reference

Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70years of age or older

10.1002/cncr.23360 · 2008 · External reference

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer

10.1200/jco.2000.18.13.2529 · 2000 · External reference

Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems

10.1111/j.1365-2125.2006.02744.x · 2007 · External reference

Unresolved reference

External reference

Aging biology and geriatric clinical pharmacology

10.1124/pr.56.2.4 · 2004 · External reference

Unresolved reference

2005 · External reference

Polypharmacy in the older patient with cancer

10.1177/107327489700400505 · 1997 · External reference

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

10.1002/cncr.21847 · 2006 · External reference

Polypharmacy and the risk of drug–drug interactions among Danish elderly. A prescription database study

1998 · External reference

The consumption of drugs by 75-year-old individuals living in their own homes

10.1007/s002280000157 · 2000 · External reference

Herb and supplement use in the US adult population

10.1016/j.clinthera.2005.11.004 · 2005 · External reference

Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs

10.1089/107555302760253676 · 2002 · External reference

Complementary and alternative medicine among Singapore cancer patients

10.47102/annals-acadmedsg.v39n2p129 · 2010 · External reference

Clinically based evidence of drug–herb interactions: a systematic review

10.1517/14740330903405593 · 2010 · External reference

Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management

10.1111/j.1365-2710.2007.00815.x · 2007 · External reference

Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit

10.1016/j.amjopharm.2009.05.002 · 2009 · External reference

Medication problems in older, newly diagnosed cancer patients in Canada: how common are they? A prospective pilot study

10.2165/00002512-200926060-00008 · 2009 · External reference

Polypharmacy in elderly cancer patients. 2010 ASCO Annual Meeting; June 2010. Chicago, poster

10.1200/jco.2010.28.15_suppl.9074 · 2010 · External reference

Drug–drug interactions in oncology: why are they important and can they be minimized?

10.1016/j.critrevonc.2005.03.007 · 2005 · External reference

Understanding and preventing drug interactions in elderly patients

10.1016/j.critrevonc.2003.04.004 · 2003 · External reference

Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study

10.1016/s0959-8049(02)00090-4 · 2002 · External reference

Polypharmacy: the cure becomes the disease

10.1007/bf02600099 · 1993 · External reference

National surveillance of emergency department visits for outpatient adverse drug events

10.1001/jama.296.15.1858 · 2006 · External reference

Drug-induced illness as a cause for admission to a community hospital

10.1111/j.1532-5415.1989.tb05498.x · 1989 · External reference

Impact of comorbidity on survival of Danish prostate cancer patients, 1995–2006: a population-based cohort study

10.1016/j.urology.2007.12.018 · 2008 · External reference

Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study

10.1038/sj.pcan.4500868 · 2006 · External reference

Comorbidity and ovarian cancer survival in Denmark, 1995–2005: a population-based cohort study

10.1111/j.1525-1438.2007.01036.x · 2008 · External reference

Multimorbidity and survival in older persons with colorectal cancer

10.1111/j.1532-5415.2006.00973.x · 2006 · External reference

Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients

10.1007/s00432-007-0233-x · 2007 · External reference

International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients—an analysis of the medical literature

10.1200/jco.2007.10.6583 · 2007 · External reference

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy

10.1007/s10549-005-1410-8 · 2005 · External reference

Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients

10.1016/j.ygyno.2008.01.001 · 2008 · External reference

Unresolved reference

External reference

Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials

10.1200/jco.2007.12.8322 · 2008 · External reference

Predictors of treatment failures during chemotherapy: a prospective study on 110 older cancer patients

10.1016/j.archger.2008.01.011 · 2003 · External reference

10.1016/j.ejca.2010.04.009

10.1016/j.ejca.2010.04.009 · External reference

Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >=70years with advanced ovarian cancer—a study by the AGO OVAR Germany

10.1093/annonc/mdl401 · 2007 · External reference

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

10.1093/jnci/94.3.173 · 2002 · External reference

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer

10.1200/jco.2006.06.9039 · 2006 · External reference

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study

10.1200/jco.2005.09.102 · 2005 · External reference

Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy

10.1080/1042819031000119262 · 2003 · External reference

Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancer

10.1016/0959-8049(92)90459-f · 1992 · External reference

Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy

10.1002/cncr.22939 · 2007 · External reference

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

10.1016/j.ejca.2006.05.002 · 2006 · External reference

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

10.1200/jco.2006.06.4451 · 2006 · External reference

NCCN clinical practice guidelines in oncology

2008 · External reference

On behalf of the ESMO Guidelines Working Group: erythropoiesis-stimulating agents in cancer patients: ESMO recommendations for use

10.1093/annonc/mdp161 · 2009 · External reference

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

10.1001/jama.299.8.914 · 2008 · External reference

Unresolved reference

External reference

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

10.1038/sj.bjc.6605498 · 2010 · External reference

Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events

10.1038/sj.bjc.6605255 · 2009 · External reference

Erythropoietin or Darbepoetin for patients with cancer—meta-analysis based on individual patient data

2009 · External reference

Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations

10.1093/annonc/mdm011 · 2007 · External reference

Dose adjustment and supportive care before and during treatment

10.1016/j.ctrv.2009.04.009 · 2009 · External reference

Updated clinical practice guidelines for the prevention and treatment of mucositis

10.1002/cncr.22484 · 2007 · External reference

Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research

10.1200/jco.1989.7.11.1693 · 1989 · External reference

Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study

2007 · External reference

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference

10.1093/annonc/mdj078 · 2006 · External reference

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006

10.1200/jco.2006.06.9591 · 2006 · External reference

On behalf of the ESMO Guidelines Working Group: chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis

10.1093/annonc/mdp160 · 2009 · External reference

Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients

10.1016/j.critrevonc.2008.12.006 · 2009 · External reference

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

10.1200/jco.2004.07.173 · 2004 · External reference

Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study

10.1093/annonc/mdl321 · 2007 · External reference

Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia

10.1016/j.ejca.2006.06.017 · 2006 · External reference

Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors

10.1200/jco.2006.08.9599 · 2007 · External reference

Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes

10.1200/jco.2002.09.064 · 2002 · External reference

Coprescription of tamoxifen and medications that inhibit CYP2D6

10.1200/jco.2009.23.8931 · 2010 · External reference